Curaen
Free reference · no signup

The SNP cheat-sheet

The genetic variants that actually change what to take and eat, with what each genotype means and what to do about it. Look yours up in your own raw data; most lines are sourced to a named study.

35 genes 41 variants 35 cited to PubMed 6 safety flags
Download the PDF → Yours to keep, print, and share.

How to read this

  1. 1.Open your 23andMe or AncestryDNA raw data, the plain-text download.
  2. 2.Search it (Ctrl/Cmd‑F) for any rsID below.
  3. 3.Find your two letters in the row. Read what they mean, and what to do.

Strand note  Genotypes are written on the dbSNP plus strand. If your file shows the complementary letters (A↔T, C↔G, so you might see CT where we wrote AG), that's the same result read from the other strand. Match by the variant, not by an exact letter.

Methylation & B-vitamins

5 genes

FUT2 · Fucosyltransferase 2 (secretor status)

Full guide →
rs601338 FUT2 W154X secretor variant

This is the switch that decides whether you make a working FUT2 enzyme. The G allele builds a functional enzyme (secretor). The A allele inserts a premature stop, so the enzyme comes out truncated and dead (non-secretor). Two A copies means no working enzyme at all. Note on reading your own data: this site is reported on one DNA strand, but a 23andMe or AncestryDNA export may print the complementary letters for this position (C instead of G, T instead of A). The biology is identical. If your file shows C/C, T/T, or C/T, read those as G/G, A/A, and G/A here.

GG
Secretor. Both copies of FUT2 work, so you make the enzyme normally. Tends to go with a more average total B12 reading. About 80% of Europeans carry at least one G.
GA
One working copy, one broken. Still a secretor in practice, since one good copy is enough to make the enzyme. B12 reading lands in the typical range.
AA
Non-secretor. Both copies carry the stop, so you make no functional FUT2 enzyme. Studies link this to a total serum B12 reading about 16 to 18 percent higher than secretors, but the extra is mostly the parked haptocorrin-bound form, not the active form your cells use. A high number here doesn't guarantee you're well-stocked.
Do

FUT2 (rs601338) sets your secretor status: G makes a working enzyme, A breaks it, and AA means you make none.

PubMed 29040465 · found rs601338 AA (non-secretor) had 16 to 18 percent higher total serum B12 and higher holo-haptocorrin, while holo-transcobalamin (the bioactive carrier) was not influenced by the variant.

MTHFR · Methylenetetrahydrofolate reductase

Full guide →
rs1801133 C677T

The variant everyone studies. The T allele builds an enzyme that's slower and falls apart in heat.

GG
Typical activity. Nothing to change here.
GA
One copy. Roughly a third less enzyme activity.
AA
Two copies. Activity drops a lot, and this is where switching to methylfolate makes the most sense.
rs1801131 A1298C

The second common one. Gentler by itself, and mostly studied next to C677T rather than alone.

TT
Typical activity.
TG
One copy. Activity is a little lower.
GG
Two copies. Still only a little lower.
Do

Go with L-methylfolate (5-MTHF) instead of folic acid. It's already activated, so the slow MTHFR step never enters the picture.

PubMed 38892484 · MTHFR genotype & methylfolate homocysteine response

MTRR · Methionine synthase reductase

Full guide →
rs1801394 A66G

The G allele tracks with slower B12 regeneration.

AA
Normal recycling speed.
AG
One copy. A modest dip.
GG
Two copies. The slowest of the three, so your B12 status matters most here.
Do

If you take B12, reach for methylcobalamin (the active form) over the cheap cyanocobalamin.

PubMed 37917901 · MTRR A66G & B12 / homocysteine status

PEMT · Phosphatidylethanolamine N-methyltransferase

Full guide →
rs7946 rs7946 (V175M)

The T allele means you build less phosphatidylcholine on your own, so more of your choline has to come from the plate.

CC
Normal choline production.
CT
Lower production, so you need more choline from food.
TT
The lowest production, and where the choline argument is strongest.
Do

Lean on choline-rich foods like eggs and liver, and add a supplement if your intake runs low.

PubMed 37513629 · PEMT rs7946 modifies choline's effect on hepatic steatosis

SLC19A1 · Reduced folate carrier (SLC19A1)

Full guide →
rs1051266 SLC19A1 c.80G>A

SLC19A1 sits on the minus strand of chromosome 21, so VCF allele labels and coding-strand notation run in opposite directions. T (VCF reference) = c.80A on the coding strand; C (VCF alternate) = c.80G. In the one population study with data on rs1051266, women homozygous for c.80G (that is, CC in VCF terms) had lower RBC folate than women carrying one or two A alleles. The variant accounted for roughly 5% of the RBC folate variation among women. No association appeared in men, and serum folate and homocysteine were unaffected in either sex.

TT (homozygous reference; coding AA)
Associated with higher red blood cell folate in women in the studied population. The A allele looks like the higher-folate form, at least in one Northern Irish cohort. Not a diagnosis of anything good, just a modestly favorable signal on one biomarker.
TC (heterozygous; coding AG)
Women with one copy of each allele had higher RBC folate than CC women, similar in direction to TT. Treat this as a single data point from one study. The difference is real enough to be statistically significant, but the biology here is not fully mapped.
CC (homozygous alternate; coding GG)
Lower RBC folate in women. This is the at-risk group in the one study that measured it. Even so, the SNP explains only 5% of variance in that biomarker, so your actual folate intake is doing far more work than your genotype.
Do

The rs1051266 association with RBC folate showed up in women but not in men within the same cohort. Nobody knows why. CC women had lower RBC folate; TT women had higher levels. The effect size is genuinely modest: this single SNP accounts for 5% of RBC folate variance, so what you eat moves the needle far more than which allele you carry.

PubMed 19650776 · rs1051266 (c.80G>A) explained ~5% of RBC folate variance in women; no serum folate or homocysteine association; association absent in men

Vitamins & minerals

6 genes

BCO1 · Beta-carotene oxygenase 1 (beta-carotene 15,15'-monooxygenase)

Full guide →
rs7501331 A379V — the well-studied slow variant

rs7501331 is the workhorse variant here, the one with the cleanest human data. It changes amino acid 379 from alanine to valine, which is why you'll see it written as A379V. The T allele is the slow one. Heads up on letters: this comes from dbSNP, and a 23andMe or AncestryDNA export reads whichever strand the chip uses, so yours may print the complementary letters instead (a C shows as G, a T shows as A). Match by pattern, not by assuming the letter is wrong.

CC
Typical converter. Both copies are the reference allele, so your BCO1 enzyme handles beta-carotene at full pace. You can generally get enough vitamin A from a normal mix of plant and animal foods.
CT
One slow copy. Conversion sits somewhere in the middle. In the human study, carrying the 379V (T) allele was tied to a lower ability to turn beta-carotene into vitamin A, so plant sources work a bit less efficiently for you.
TT
Two slow copies. This is the lowest-conversion version of this variant. The 379V allele was linked to a 32% drop in beta-carotene-to-vitamin-A conversion in female volunteers, and unconverted beta-carotene tends to run higher in your blood. Preformed retinol is the more reliable vitamin A source.
rs12934922 R267S — the partner variant

rs12934922 changes amino acid 267 from arginine to serine (R267S). On its own the evidence for a big effect is thin. Where it earns its place is in combination: people carrying the slow alleles of both this SNP and rs7501331 were the worst converters in the study, well below people carrying just one. So read this row alongside the first. Same letter caveat applies: on a 23andMe-style export an A may print as a complementary T, so match by pattern.

AA
Reference at this spot. No added slowdown from this variant. Your overall conversion still depends on what you carry at rs7501331.
AT
One copy of the 267S (T) allele. Minor effect by itself. It matters most when paired with a slow rs7501331 genotype, where the two together stack up.
TT
Two copies of the 267S allele. Alone this had little measured effect, but combined with the slow rs7501331 variant it marked the largest conversion drop in the study (about 69% lower). Check both variants together to read your real conversion picture.
Do

BCO1 builds the enzyme that turns plant beta-carotene into usable vitamin A.

PubMed 19103647 · in female volunteers, the rs7501331 (A379V) variant allele was associated with a 32% lower conversion of beta-carotene to vitamin A, and carrying the slow alleles of both rs7501331 and rs12934922 was associated with a 69% lower conversion plus higher circulating beta-carotene.

CYP2R1 · Cytochrome P450 2R1

Full guide →
rs10741657

The G allele tracks with lower 25(OH)D and a higher shot at deficiency. Reading note: this site is reported here on the forward strand (alleles A and G). A 23andMe or AncestryDNA export may print the complementary letters T and C instead, where C lines up with G (the lower-vitamin-D version) and T with A. Match by the variant, not the exact letter.

AA
Typical vitamin-D activation.
AG
One copy. Levels tend to run a bit lower.
GG
Two copies. Lowest of the three, and the genotype where a blood test earns its keep most.
Do

Get a 25(OH)D test. Genes shift the odds; your blood level is what's actually true.

PubMed 30120973 · CYP2R1 rs10741657 & 25(OH)D / deficiency risk

GC · GC vitamin-D binding protein

Full guide →
rs7041 rs7041 (D432E)

The A allele is linked to weaker vitamin-D transport.

AA
Two copies. The lowest transport of the three, and the genotype where checking your level pays off most.
AC
One copy. Transport runs a bit lower, so deficiency is more likely.
CC
Typical transport.
Do

Test your 25(OH)D instead of guessing. Genes tilt the odds; the number on the lab report is what actually counts.

PubMed 29196501 · GC rs7041 (vitamin-D binding protein) & serum 25(OH)D

SLC23A1 · Solute Carrier Family 23 Member 1 (SVCT1, sodium-dependent vitamin C transporter 1)

Full guide →
rs33972313 rs33972313 (SVCT1 transporter efficiency)

A single-letter change in SLC23A1 that slightly lowers how efficiently the SVCT1 transporter moves vitamin C into your blood. The T allele is the less common, lower-transport version. Note: this site is read on different strands by different labs, so a 23andMe export may print the complementary letters G and A instead of C and T (C reads as G, T reads as A). Same variant, mirrored letters.

CC
Two standard copies. Your SVCT1 moves vitamin C the usual way, so on a given diet your plasma level lands in the typical range. The most common result.
CT
One standard copy and one lower-transport copy. On the same diet you tend to sit somewhat lower than CC. In the study below, each lower-transport copy tracked with about 6 micromol/L less plasma vitamin C, so a single copy is a modest shift. Food still matters most; this just nudges your baseline.
TT
Two lower-transport copies. The least common result, and the one that tracks with the lowest circulating vitamin C for a given intake. All the more reason to keep produce steady rather than sporadic.
Do

SLC23A1 builds SVCT1, the transporter that decides how much of the vitamin C you eat actually reaches your blood.

PubMed 20519558 · (Timpson et al., Am J Clin Nutr 2010) — across 15,087 people in five cohorts, each copy of the rs33972313 minor (lower-transport) allele was associated with about 6 micromol/L lower circulating L-ascorbic acid (pooled estimate -5.98 micromol/L, 95% CI -8.23 to -3.73).

TMPRSS6 · Transmembrane serine protease 6

Full guide →
rs855791 rs855791 (V736A)

The G allele tends to track with slightly lower iron and hemoglobin.

AA
Typical iron and hemoglobin tendency.
AG
One copy of the G allele, so a slightly lower lean.
GG
Two copies of G, the lowest lean of the three, though your labs still have the final say.
Do

Genetics alone isn't a reason to start iron. Check ferritin and iron in your blood first.

PubMed 39991164 · TMPRSS6 rs855791 & iron status / hepcidin

VDR · Vitamin D Receptor

Full guide →
rs2228570 FokI (start-codon variant)

This one sits right where the receptor protein starts being built, so it actually changes the protein. In a year-long trial on a fixed daily dose of vitamin D, the genotype groups raised their blood levels by different amounts, and one group came out clearly at the bottom.

AA
Largest rise among the groups. Sits at the opposite end of the gradient from the lowest responders, so on the same daily amount this group tends to move its blood level the most.
AG
In between. One copy of each, an intermediate response.
GG
Smallest rise per dose. In the trial this was the lowest-responding group on the same daily amount and may need a higher dose to reach the same blood level. Educational only, not a dosing instruction.
rs1544410 BsmI (intron variant)

This one sits in a non-coding stretch, so it doesn't change the receptor protein itself. It's a marker that's been linked to baseline vitamin D differences, but studies disagree on the direction from one population to the next, so we won't hand you a dosing rule from it.

CC
Common version. Linked to vitamin D variation in some studies, but the direction isn't consistent across groups.
CT
One copy of each. Intermediate, with the same caveat about mixed evidence.
TT
The other version. Some studies tie it to lower baseline vitamin D, others to higher; the signal isn't settled.
Do

FokI changes the actual receptor protein, which gives it the clearest link to how efficiently a vitamin D dose turns into a blood level.

PubMed 28811597 · (Scientific Reports, 2017; 204 patients with type 2 diabetes, 2,000 IU/day vitamin D3 for 12 months) — the lowest increment in serum 25(OH)D was seen in the FokI lowest-responder genotype (reported as Fok-I CC, which is GG on the dbSNP forward strand), p<0.0001; the paper did not publish per-genotype ng/mL change values.

Fats & lipids

4 genes

APOA2 · Apolipoprotein A-II

Full guide →
rs5082 APOA2 -265T>C

A promoter variant that alters how saturated fat intake influences APOA2 gene expression and body weight regulation.

CC
Higher body weight risk specifically when saturated fat intake is high; epigenetic changes reduce APOA2 expression.
CT
Intermediate response; effects depend on specific saturated fat levels.
TT
Lower body weight risk relative to CC carriers when saturated fat intake is high; maintains higher APOA2 expression under high SFA conditions.
Do

The CC genotype is associated with increased body weight risk only when saturated fat intake is high, not uniformly.

PubMed 29901700 · APOA2 rs5082 CC carriers showed lower APOA2 expression and higher obesity risk on high-saturated-fat diets (Am J Clin Nutr, 2018).

APOA5 · Apolipoprotein A5

Full guide →
rs662799 -1131T>C

The variant (G) allele is tied to a bigger triglyceride jump after meals heavy in dietary fat.

GG
Two copies of the higher-response allele. This is where the omega-3 and lower-refined-carb case is strongest.
GA
One copy. Your triglycerides tend to react more than average.
AA
A typical triglyceride response.
Do

Preformed omega-3 (EPA/DHA) is a proven way to lower triglycerides, and it's worth more to your genotype.

PubMed 19159622 · APOA5 -1131T>C (rs662799) & plasma triglycerides

APOE · Apolipoprotein E

Full guide →
rs429358 The e4-defining spot

This is the position that creates the e4 version of APOE. A C here is the e4-defining letter; a T is the non-e4 (e2/e3) letter. Note: a 23andMe or AncestryDNA export reads the other DNA strand for this spot, so it may print these as G (for C) and A (for T). Match by position, not just the letter.

TT
No e4 from this spot. Your saturated-fat-to-LDL response is the typical, less reactive one. Pair this with rs7412 to get your full e2/e3 type.
TC
One e4 copy. You carry e4. In diet studies, one e4 copy is enough to make your LDL more responsive to saturated fat, up when it's high, down when you cut it.
CC
Two e4 copies (e4/e4). The most fat-responsive type. Your LDL tends to move the most with changes in saturated fat intake.
rs7412 The e2-defining spot

This is the position that creates the e2 version. A T here is the e2-defining letter; a C is the non-e2 (e3/e4) letter. Note: on a 23andMe-style export this spot may print as A (for T) and G (for C) because it reads the complementary strand. Read the two spots together to land your final type.

CC
No e2 from this spot. Combined with the other SNP, you're an e3 or e4 type, the more saturated-fat-responsive end of the range.
CT
One e2 copy. The e2 version binds the liver receptor weakly and generally tracks with lower LDL. One copy nudges your profile toward the less-reactive side.
TT
Two e2 copies (e2/e2). The least common type. Cholesterol handling works quite differently here, so general APOE rules of thumb don't map cleanly; worth a conversation with a clinician if this is you.
Do

APOE has three common versions (e2, e3, e4), and your version sets how much your LDL cholesterol reacts to dietary saturated fat.

PubMed 11257255 · combined analysis of controlled feeding studies found the LDL-cholesterol increase per unit of dietary saturated fat was about 0.08 mmol/L larger in people with the e3/4 or e4/4 genotype than in e3/3.

FADS1 · Fatty acid desaturase 1

Full guide →
rs174546

The T allele tracks with reduced FADS1 (delta-5 desaturase) activity, the step that builds longer-chain fats like arachidonic acid, EPA and DHA from shorter ones. The effect is clearest on arachidonic acid; the shift in EPA and DHA is real but smaller and varies between studies.

CC
Typical desaturase activity.
CT
Somewhat lower activity.
TT
Lowest of the three. If your omega-3s come mostly from plant ALA, preformed EPA and DHA is the more dependable bet.
Do

If you're a slow converter, ready-made EPA and DHA do the most for you. Fish oil, or algae oil if you're vegan.

PubMed 39021601 · Rabehl et al., Front Nutr 2024. In carriers of the rs174546 minor allele, blood arachidonic acid (n-6) was significantly lower, consistent with reduced FADS1 desaturase activity; the EPA and DHA (n-3) difference trended the same way but was not statistically significant in this 85-person cohort, so the conversion effect is real with a modest measured EPA/DHA magnitude.

Metabolism: caffeine & blood sugar

3 genes

CYP1A2 · Cytochrome P450 1A2

Full guide →
rs762551 rs762551 (*1F)

The A allele is the inducible "fast" version. Carry a C and your clearance slows down.

CC
Slow clearer. Caffeine lingers, so keep it earlier and lighter.
CA
In between. Slower than two A's, faster than two C's.
AA
Fast clearer. Caffeine moves out quickly.
Do

Slow clearer? Keep caffeine to the morning and cap the total. That's the move that actually works.

PubMed 16522833 · Cornelis et al., JAMA 2006. In 2,014 first-heart-attack cases and matched controls, slow CYP1A2 metabolizers (*1F carriers) saw their risk climb with coffee intake (odds ratio 1.36 at 2-3 cups/day, 1.64 at 4 or more, and up to 2.33 in adults under 59), while fast metabolizers showed no such rise (p=0.04 for the gene-by-coffee interaction). Moderating caffeine matters most for slow clearers.

FTO · Fat Mass and Obesity-Associated Protein

Full guide →
rs9939609 FTO Intron 1

The A allele is associated with higher BMI and increased food intake, while the T allele is linked to lower intake.

AA
Higher baseline appetite and energy intake; ~0.39 kg/m² higher BMI on average.
AT
Intermediate risk profile between AA and TT.
TT
Lower baseline appetite and energy intake; reference group for lower BMI risk.
Do

The A allele nudges you toward eating more calories, not necessarily moving less. Loos and Yeo (2014) note FTO SNPs do not significantly influence physical activity levels themselves.

PubMed 24247219 · Loos & Yeo review: the FTO A allele raises BMI through appetite, and physical activity blunts the effect by ~30% (Nat Rev Endocrinol, 2014).

TCF7L2 · Transcription factor 7-like 2

Full guide →
rs7903146

T is the version that adds risk. Each copy you carry stacks the effect a bit higher.

CC
Two C's. Nothing extra coming from this variant.
CT
One T. Your type-2 diabetes risk ticks up a little.
TT
Two T's. This is the strongest signal a common variant gives, so your blood-sugar habits carry the most weight.
Do

Cutting refined carbs and moving after meals hits the exact mechanism this variant affects. That's where your effort pays off most.

PubMed 16415884 · Grant et al., Nat Genet 2006. The TCF7L2 risk variant (tagged by rs7903146) raised type-2-diabetes risk with relative risks of 1.45 for one copy and 2.41 for two, replicated across Icelandic, Danish, and US cohorts - a population-attributable risk near 21%, and the strongest common-variant signal for type-2 diabetes.

Antioxidants & cell defense

3 genes

GPX1 · Glutathione Peroxidase 1

Full guide →
rs1050450 GPX1 Pro198Leu

The proline-to-leucine swap in glutathione peroxidase 1. In your raw export the alleles read as G and A. The research literature writes the same spot as C (proline, the common, more responsive form) and T (leucine, the variant). Your 23andMe or AncestryDNA file may print the complementary letters, so don't be thrown if you see C/T instead of G/A.

GG
Two copies of the common (proline) form. In the study below, GPx1 activity tracked selenium most tightly in this group: the enzyme ramps up well when selenium is around. Standard selenium needs apply.
GA
One common copy, one variant (leucine) copy. An in-between response: the enzyme still answers to selenium, just less briskly than GG. Most people carry at least one copy of each.
AA
Two copies of the variant (leucine) form. In the study, this group showed the weakest, non-significant link between selenium and enzyme activity, which points to a blunted response. Not a deficiency, not a diagnosis. Just a flatter return on the same selenium.
Do

GPX1's enzyme runs on selenium. If you're low on it, the genotype barely matters, because the enzyme has nothing to work with.

PubMed 19415410 · in 405 adults, GPx1 enzyme activity correlated with plasma selenium most strongly in proline/proline carriers (r=0.44) and least in leucine/leucine carriers (r=0.25, not significant), showing the variant allele blunts how the enzyme responds to selenium.

NQO1 · NAD(P)H Quinone Dehydrogenase 1

Full guide →
rs1800566 Pro187Ser (NQO1*2, C609T)

The G allele builds proline at position 187 and gives you a fully working enzyme. The A allele swaps in serine, and that version of the protein is unstable. Your cell breaks it down fast, leaving much less CoQ10-recycling activity. Two A copies leaves only a small fraction of normal enzyme activity. One note: a 23andMe export reads the other DNA strand, so it may print these as C and T instead of G and A. C lines up with G (the working version), T lines up with A (the variant).

GG
Two working copies. Your NQO1 recycles CoQ10 and vitamin E at full speed. The typical, higher-activity result.
GA
One working copy, one variant copy. Activity sits in the middle, so recycling runs lower than GG but holds up better than AA.
AA
Two variant copies. The serine version of the enzyme gets degraded quickly, leaving only a small fraction of normal activity. The lowest CoQ10-recycling capacity of the three.
Do

NQO1 turns CoQ10 into ubiquinol, the form that does the antioxidant work in your membranes.

PubMed 11160862 · Siegel et al., Mol Pharmacol 2001. The NQO1*2 (Pro187Ser) protein is rapidly polyubiquitinated and degraded by the proteasome (completely cleared within about two hours, while wild-type NQO1 is not), and cells homozygous for NQO1*2 are deficient in NQO1 activity. This is the mechanism behind the unstable serine-187 enzyme and its reduced CoQ10-recycling capacity. (Direct human CoQ10-status data remain preliminary: a 54-man pilot, PubMed 21774831, found a baseline difference between genotype groups but did not cleanly show carriers run lower.)

SOD2 · Superoxide Dismutase 2 (manganese superoxide dismutase, MnSOD)

Full guide →
rs4880 Ala16Val (also written Val16Ala or c.47T>C)

This is the single most studied spot in the SOD2 gene. It changes one amino acid in the targeting label that tells the cell to ship MnSOD into the mitochondrion. The dbSNP letters here are A and G. Many consumer DNA files print the complementary letters T and C instead, because the variant can be read off either strand of the DNA. If your export shows T and C, that is the same variant read the other way around: T lines up with A, and C lines up with G. The G allele (C on the other strand) builds the version that imports cleanly and gives you more active enzyme. The A allele (T on the other strand) builds the version that partly gets stuck on the way in, leaving less working enzyme where it is needed.

GG
Both copies build the high-import version of MnSOD. The targeting label holds its shape, the enzyme reaches the mitochondria efficiently, and you make the most active MnSOD of the three genotypes. This is the alanine/alanine combination.
AG
One copy of each version. You import a working amount of MnSOD, somewhere between the other two genotypes. This is the most common result for many people and is nothing to worry about.
AA
Both copies build the lower-import version. More of the enzyme gets partly stuck on the way into the mitochondrion, so you end up with less active MnSOD than a GG carrier. Reason to be steady about feeding your antioxidant defenses, not a diagnosis of anything. This is the valine/valine combination.
Do

SOD2 makes MnSOD, the main antioxidant enzyme inside your mitochondria, where your cells produce the most free radicals.

PubMed 12618592 · showed the alanine (high-import) version of the MnSOD targeting sequence is imported efficiently into the mitochondrial matrix and produced 30 to 40 percent more active, processed enzyme than the valine (low-import) version, which was partly arrested in the inner mitochondrial membrane.

Fitness & performance

2 genes

ACTN3 · Actinin Alpha 3

Full guide →
rs1815739 R577X

This is the only ACTN3 variant that matters for the power-versus-endurance story. The letter you carry tells you whether your fast-twitch fibers contain alpha-actinin-3. Heads up on reading your raw data: dbSNP records this SNP on the minus strand, so a 23andMe export may print the complementary letters (G/A instead of C/T). If you see G/A, read G where this table says C and A where it says T.

CC
Two working copies (the R/R genotype). Your fast-twitch fibers are fully loaded with alpha-actinin-3 and lean toward fast, powerful, glycolytic contractions. This is the most power- and sprint-associated version.
CT
One working copy, one switched off (R/X). You make alpha-actinin-3, just less of it. A middle-ground profile that sits between the two extremes. This is the most common genotype in most populations.
TT
Both copies switched off by R577X (X/X), so you make no alpha-actinin-3 at all. About 16% of people worldwide. Your fast fibers shift toward more efficient aerobic metabolism and resist fatigue a bit longer during sustained effort, which tilts the profile toward endurance.
Do

R577X (rs1815739) is the single switch. CC means full alpha-actinin-3, TT means none, CT is in between.

PubMed 17828264 · knockout of alpha-actinin-3 in mice shifted fast-twitch muscle metabolism toward the more efficient aerobic pathway and raised intrinsic endurance, showing the protein's presence keeps fast fibers tilted toward anaerobic, power-style energy use.

ADRB2 · Beta-2 Adrenergic Receptor

Full guide →
rs1042713 Arg16Gly

Swaps one amino acid (position 16) at the start of the beta-2 receptor, changing how the receptor behaves under repeated adrenaline. Often pitched as the fat-burning variant. It mostly isn't. Here the G allele codes glycine (Gly16) and the A allele codes arginine (Arg16).

GG
Gly16/Gly16, the more common form in many groups. The more responsive setup: under direct beta-agonist stimulation in the lab, the glycine form shows the fuller rise in free fatty acids and fat oxidation. In real training, the everyday difference is small.
GA
One copy of each, glycine and arginine. Intermediate, and where a lot of people land. No reliable real-world advantage or penalty for exercise fat loss.
AA
Arg16/Arg16. In controlled studies that infused a beta-agonist and measured fat release directly, this arginine form showed a blunted rise in free fatty acids and glycerol and a bit less fat oxidation, more so in women. It is a modest cellular difference under drug stimulation, not a measured penalty you would feel during normal training.
Do

Don't buy a supplement because of your ADRB2 result. No pill reliably rewires how this receptor answers adrenaline, and the genotype effect is too small to chase with one. The thing that produces adrenaline on demand, and trains your fat cells to respond to it, is exercise itself.

PubMed 17130852 · Jocken et al., Int J Obes (Lond) 2007;31(5):813-9: under stepwise infusion of the beta-agonist isoprenaline, the ADRB2 Arg16 allele tracked with a blunted increase in circulating free fatty acids and glycerol and decreased fat oxidation during beta-adrenergic stimulation, with the effect stronger in women than men

Brain & temperament

2 genes

BDNF · Brain-Derived Neurotrophic Factor

Full guide →
rs6265 Val66Met

A single C-to-T change that swaps valine (Val) for methionine (Met) at position 66 in the BDNF protein. The C allele is the valine version (full activity-dependent release); the T allele is the methionine version (the one that blunts release). The reduction generally tracks with the number of T copies you carry.

CC
Two valine copies. This is the standard version, with the most efficient activity-dependent BDNF release. Your brain packages and dispatches BDNF normally when neurons fire.
CT
One valine, one methionine. Activity-dependent BDNF release is modestly reduced compared to CC, sitting between the two homozygous genotypes. The steady background release is unaffected; only the activity-triggered burst is dialed down.
TT
Two methionine copies. This genotype shows the largest reduction in activity-dependent release. Background (constitutive) release stays normal; it's the burst tied to neural activity that takes the biggest hit.
Do

rs6265 (Val66Met) tweaks how efficiently your brain releases BDNF during neural activity, not whether you make it at all.

PubMed 12553913 · showed that neurons carrying the methionine version of BDNF had lower depolarization-induced (activity-dependent) secretion while steady background (constitutive) secretion was unchanged, pinning the effect to the activity-triggered release pathway.

COMT · Catechol-O-methyltransferase

Full guide →
rs4680 Val158Met

A G-to-A change at this spot swaps valine for methionine in the enzyme. The methionine version is less stable at body temperature, so it clears dopamine more slowly. Activity steps down across the three genotypes: GG is fastest, AA is slowest, GA sits in the middle. Note on testing: rs4680 is reported here on the strand where the variant reads as G or A. A 23andMe or AncestryDNA export may print the complementary letters instead (C for G, T for A), so an AA result there could show up as TT. Same variant, just the other strand.

GG
Two copies of the valine (Val) version. This is the fast, heat-stable enzyme, so dopamine gets cleared quickly. The 'warrior' end. Lower resting prefrontal dopamine; often described as steadier under stress, less sharp on tasks that need peak focus.
GA
One Val, one Met. Intermediate enzyme activity and intermediate dopamine clearance. The most common genotype, and biochemically the middle of the road.
AA
Two copies of the methionine (Met) version. This is the slower, less heat-stable enzyme, so dopamine lingers longer. The 'worrier' end. Higher resting prefrontal dopamine; often linked to better focus when calm but more sensitivity to stress.
Do

rs4680 sets your dopamine-clearance speed in the prefrontal cortex: GG clears fast, AA clears slow, GA is in between.

PubMed 7703232 · characterized the kinetics of human catechol-O-methyltransferase and described the thermolabile (low-activity, methionine) variant of the enzyme that uses S-adenosylmethionine as its methyl donor to methylate dopamine and other catecholamines.

Diet & digestion

2 genes

LCT · Lactase

Full guide →
rs4988235 rs4988235 (-13910 C/T)

The T (A) allele confers lactase persistence; it's dominant, so one copy is usually enough.

AA / TT
Lactase persistent — usually tolerate dairy.
AG / CT
One persistence copy — usually still tolerate dairy.
GG / CC
Non-persistent — little adult lactase; dairy more likely to bother you.
Do

Non-persistent? A lactase pill with dairy, or lactose-free products, handles most of it.

PubMed 11788828 · Enattah et al., Nat Genet 2002. Identified the regulatory variant (rs4988235, the -13910 C/T upstream of LCT) associated with adult-type hypolactasia: the persistence allele keeps lactase expression switched on past weaning, the other does not.

TAS2R38 · Taste 2 Receptor Member 38 (bitter taste receptor)

Full guide →
rs713598 TAS2R38 A49P (alanine/proline at position 49)

This single letter change swaps one amino acid in the bitter-taste receptor at position 49. In the orientation we use here, the C version builds the sensitive (proline) receptor and the G version builds the sluggish (alanine) one. It travels with two nearby variants as a package, but this site does a lot of the work on its own. One caution worth knowing: this is a notoriously strand-flippable SNP. Consumer files (like 23andMe or AncestryDNA) report it with the letters C and G, but different labs read it from opposite DNA strands, so the same physical result can be printed with the taster and non-taster letters swapped relative to the rows below. Because of that, the safest way to read your result is by the taster vs non-taster interpretation your provider gives you, or a strand-aware lookup tool, rather than hand-matching the raw C/G letters from your file.

CC
Two copies of the sensitive build. You are most likely a strong bitter taster: PTC paper tastes harsh, and raw cruciferous greens can read as genuinely bitter. In a controlled taste study, CC tongues detected the bitter compound PROP at the lowest concentrations.
CG
One of each. Intermediate sensitivity. Bitter greens register, but usually as background rather than a wall. Most people fall here.
GG
Two copies of the quiet build. You are likely a bitter non-taster: PTC paper tastes like plain paper, and the bitterness in kale or sprouts mostly slips past you. Carriers of the G version needed higher concentrations before they could detect PROP at all.
Do

rs713598 helps set how bitter cruciferous vegetables taste to you. CC is the sensitive build, GG is the quiet one, CG sits in between.

PubMed 28738701 · measured taste responsiveness by rs713598 genotype and found the CC genotype detected the bitter compound PROP at lower concentrations than G-allele carriers, with no biochemical or body-composition differences between genotypes

Other traits

2 genes

CETP · Cholesteryl ester transfer protein

Full guide →
rs708272 TaqIB

This variant sits in the CETP gene and is one of the most replicated genetic associations with HDL cholesterol in the literature. The A allele (B2) links to lower CETP activity and higher HDL; the G allele (B1) to higher activity and lower HDL. One thing worth knowing: the often-cited 14% HDL difference comes from a two-SNP diplotype combining rs708272 with a second CETP variant. The single-SNP effect at rs708272 alone is directionally consistent but smaller.

GG (B1/B1)
Both copies are the B1 allele, linked to higher CETP activity and more cholesterol transferred away from HDL particles. B1/B1 carriers tend to have the lowest HDL of the three genotypes. The direction of the effect is well established; the full magnitude shows up when rs708272 is analyzed together with a nearby CETP variant as a diplotype, not from this SNP alone.
GA (B1/B2)
One copy of each. CETP activity and HDL levels land between the two homozygous groups. The most common genotype in many populations.
AA (B2/B2)
Both copies are the B2 allele. Lower CETP activity, HDL stays in circulation longer. When rs708272 is analyzed in a two-SNP diplotype with the nearby -4502C>T variant, the B2B2/TT group showed HDL about 14% higher than the B1B1/CC group in a Mediterranean cohort of over 4,200 people. That figure belongs to the diplotype, not to rs708272 by itself.
Do

Your rs708272 genotype shifts your HDL baseline in a predictable direction: B2/B2 (AA) toward higher, B1/B1 (GG) toward lower. The often-cited 14% HDL difference is a diplotype figure from combining rs708272 with a second CETP variant. Real, but not from this SNP in isolation.

PubMed 39920518 · case-control study finding significantly higher physical activity in high-HDL individuals versus normal-HDL controls (METs 4680 vs 1680, p=0.013)

GSTM1 · Glutathione S-transferase Mu-1

Full guide →
whole-gene deletion (copy-number variant) GSTM1 null vs functional

GSTM1 varies by deletion of the entire gene, so the meaningful states are 'functional' (at least one working copy) or 'null' (both copies deleted) — not a genotype like AA/AG/GG.

Functional (present)
You carry at least one working copy and make the GSTM1 enzyme.
Null (both copies deleted)
Roughly half of people, varying by ancestry. You make no GSTM1 enzyme; related glutathione S-transferases handle much of the same job.

Safety flags

6 genes

These don't sell a supplement. They're worth knowing before you take one.

ALDH2 · Aldehyde dehydrogenase 2

Full guide →
rs671 rs671 (*2)

The A allele builds an enzyme that barely works. One copy is enough to give you the flush.

GG
Two working copies. This variant won't make you flush.
GA
One copy (*1/*2). You'll flush — and if you keep drinking anyway, this is actually the higher-risk group for esophageal cancer: you keep just enough enzyme to tolerate alcohol while toxic acetaldehyde builds up.
AA
Two copies (*2/*2). The enzyme is essentially dead, so the flush is severe — most people who carry it simply can't drink, which keeps real-world risk low. The danger appears only if alcohol is pushed past the reaction.
Flag

Alcohol hits you harder than it hits most people. Your ALDH2 variant slows the breakdown of acetaldehyde, the toxic step between alcohol and a hangover, which is what causes the flush. It also means regular drinking carries a much higher esophageal cancer risk for you. The reliable move is to drink less or skip it. This is a warning light, not a diagnosis, so talk it through with your doctor.

PubMed 37795758 · ALDH2 rs671, alcohol & esophageal squamous cell carcinoma

CYP2C19 · Cytochrome P450 Family 2 Subfamily C Member 19

Full guide →
rs4244285 CYP2C19 *2 (681G>A)

This is the most common loss-of-function version of CYP2C19. The reference (working) allele is G; the A allele is the broken *2 version. Count your A's to find your metabolizer category. Heads up: a 23andMe or AncestryDNA export reads the opposite DNA strand for this position, so it may print your result as C and T instead of G and A. C lines up with G, and T lines up with A, so a file showing CC, CT, or TT maps to GG, GA, and AA here.

GG
Two working copies. You're a normal (extensive) metabolizer. Activator drugs like clopidogrel get switched on as expected, and CYP2C19-cleared drugs leave at the usual rate. This is the version most drug labels are written around.
GA
One working copy, one broken *2 copy. You're an intermediate metabolizer. You make somewhat less functional enzyme, so activator drugs may work a bit less and cleared drugs may run a bit higher than average.
AA
Two broken *2 copies. You're a poor metabolizer. You make little to no working CYP2C19. Activator drugs like clopidogrel are weakly activated, and CYP2C19-cleared drugs can climb to much higher levels than normal.
Flag

rs4244285 is the CYP2C19 *2 allele. G is the working version; A is the broken one. More A's means less functional enzyme.

PubMed 19106084 · in 162 healthy subjects, carriers of a reduced-function CYP2C19 allele had a 32.4% lower plasma exposure to the active metabolite of clopidogrel than non-carriers, confirming the A (*2) allele reduces CYP2C19 enzyme activity

CYP2C9 · Cytochrome P450 Family 2 Subfamily C Member 9

Full guide →
rs1799853 CYP2C9*2

This is the classic reduced-function variant of CYP2C9. The reference letter is C (the normal, full-speed enzyme) and the variant letter is T (the *2 version, an Arg144Cys swap that slows the enzyme down). Each T copy you carry means slower warfarin clearance and, in practice, a lower dose to reach the same effect. Note on your raw data: 23andMe and some other exports read the opposite DNA strand, so they may print these as G and A instead of C and T (CC shows as GG, CT as AG, TT as AA). Same variant, just the complementary letters.

CC
Two reference copies (*1/*1). Full-speed enzyme. Warfarin and NSAIDs clear at the typical rate. This is the most common genotype and needs no special note beyond standard care.
CT
One *2 copy (heterozygote). The enzyme runs slower. In a single-dose study of healthy people, one *2 copy cut S-warfarin clearance by about 25% versus CC. People with this genotype often reach a stable warfarin effect on a somewhat lower dose.
TT
Two *2 copies (*2/*2). The slowest of these three. Warfarin clears even less efficiently than with one copy, so dosing tends to be lower still. Less common than CC or CT.
Flag

CYP2C9 is a drug-metabolism gene. It decides how fast your liver clears warfarin and many NSAIDs, not how you respond to any supplement.

PubMed 27878474 · in 150 healthy subjects given a single warfarin dose, one CYP2C9*2 (rs1799853) allele reduced S-warfarin oral clearance by ~25% and hydroxy-warfarin formation clearance by ~45% versus *1/*1, confirming the *2 enzyme metabolizes warfarin more slowly.

G6PD · Glucose-6-phosphate dehydrogenase

Full guide →
rs1050828 G6PD A- (rs1050828)

One of the most common deficiency variants, seen mostly in people of African ancestry.

CC
Typical. No deficiency variant here.
CT
One copy. In women (two X chromosomes) this is carrier-level — play it safe with strong oxidants. In men (one X), a single variant copy means full deficiency — treat it as deficient.
TT
Deficiency variant present (both copies — or a single copy in men). Skip high-dose oxidants.
rs5030868 G6PD Mediterranean (rs5030868)

A harsher form of the deficiency than the A- variant.

GG
Typical. No deficiency variant here.
GA
One copy of the Mediterranean variant. Carrier-level in women; in men (one X), a single copy means full Mediterranean deficiency — strict avoidance.
AA
Mediterranean deficiency (both copies, or a single copy in men). Tighter avoidance than the milder forms.
Flag

You carry a G6PD-deficiency variant. With this variant, high-dose vitamin C and other strong oxidants can make your red blood cells break apart, which is called hemolysis. Keep vitamin C to normal food and RDA amounts. This hits men hardest, since they only have one X copy and no second gene to fall back on. Treat it as a flag to act on, not a diagnosis. A doctor can confirm your G6PD status with a simple blood test.

PubMed 38898838 · G6PD deficiency & vitamin C hemolysis

HFE · Homeostatic iron regulator

Full guide →
rs1800562 C282Y

The big one for hemochromatosis. The risk runs highest when you carry two copies.

GG / typical
No C282Y copy.
GA
One copy, so you're a carrier.
AA
Two copies, the classic high-risk hemochromatosis genotype.
rs1799945 H63D

The gentler variant. It pushes iron up more if you carry two copies, or pair one with C282Y.

CC / typical
No H63D copy.
CG
One copy.
GG
Two copies, which points to higher iron absorption.
Flag

The HFE C282Y variant is the main genotype behind hereditary hemochromatosis (iron overload). The real risk, though, sits with people who carry two C282Y copies. One copy (a carrier), or the gentler H63D variant on its own, is much milder. If you're in that higher-risk group, avoid iron-containing supplements and don't pair high-dose vitamin C with iron-rich meals, unless a doctor has reviewed your iron labs.

PubMed 29620054 · HFE C282Y & iron overload

SLCO1B1 · Solute Carrier Organic Anion Transporter Family Member 1B1 (OATP1B1)

Full guide →
rs4149056 rs4149056 (SLCO1B1 c.521T>C, Val174Ala)

This is the single best-studied SLCO1B1 variant. The T allele is the normal, full-speed transporter. Each C allele slows the liver doorman down, so the active statin clears more slowly and sits in the blood at higher levels. The direction is consistent: more C, more exposure.

TT
Normal OATP1B1 function. Your liver pulls statins out of the blood at the usual rate, so blood levels stay in the expected range. This is the reference group in the research.
TC
One slowed-down copy, an intermediate effect. In a single-dose simvastatin study, active simvastatin acid in the blood ran higher than in TT carriers but lower than in CC carriers (CC exposure was about 120% above the TC group). A common, real result, and one worth flagging to a prescriber.
CC
Two slowed-down copies, the strongest effect. In that same study, active simvastatin acid exposure ran about 221% higher than in TT carriers. This is the genotype most associated with elevated statin blood levels, and the most reason to discuss statin choice and dose with a clinician.
Flag

SLCO1B1 controls a liver transporter (OATP1B1) that clears statins from your blood. rs4149056 is the variant that matters most.

PubMed 17108811 · single 40-mg simvastatin dose in volunteers grouped by SLCO1B1 c.521 genotype; active simvastatin acid blood exposure (AUC) was 120% and 221% higher in CC carriers than in TC and TT carriers respectively, with no significant change to the inactive parent drug (simvastatin lactone).

Don't want to look up every rsID by hand?

Upload your raw file and we'll highlight exactly which rows are you: the same cited guidance, matched to your own genotypes. Read in your session, never stored.

Optional

Want to know when we add more variants?

We expand this sheet as we verify more cited variants. Leave your email and we'll tell you. Nothing else, unsubscribe anytime.